| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Viemed Healthcare (NASDAQ:VMD) will release its quarterly earnings report on Wednesday, 2025-11-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Viemed Healthcare to report an earnings per share (EPS) of $0.10.
The market awaits Viemed Healthcare's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Here's a look at Viemed Healthcare's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.06 | 0.1 | 0.07 | |
| EPS Actual | 0.08 | 0.06 | 0.1 | 0.10 |
| Price Change % | 8.00 | -12.00 | 5.0 | -2.00 |
Shares of Viemed Healthcare were trading at $6.57 as of November 03. Over the last 52-week period, shares are down 28.01%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Viemed Healthcare visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VMD
